2024-02-23 20:00:06 ET
Select Medical Holdings Corporation (SEM)
Q4 2023 Earnings Conference Call
February 23, 2024 09:00 AM ET
Company Participants
Robert Ortenzio - Executive Chairman & Co-Founder
Martin Jackson - EVP & CFO
Conference Call Participants
Justin Bowers - Deutsche Bank
Kevin Fischbeck - Bank of America
Ben Hendrix - RBC Capital Markets
Bill Sutherland - The Benchmark Company
A.J. Rice - UBS
Presentation
Operator
Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the Fourth Quarter 2023 Results and the Company's Business Outlook. Speaking today are the company's Executive Chairman and Co-founder, Robert Ortenzio; and the company's Senior Executive Vice President of Strategic Finance and Operations, Martin Jackson. Management will give you an overview of the quarter and then open the call for questions.
Before we get started, we would like to remind you that this conference call may contain forward-looking statements regarding future events or the future financial performance of the company, including, without limitation, statements regarding operating results, growth opportunities and other statements that refer to Select Medical's plans, expectations, strategies, intentions and beliefs.
These forward-looking statements are based on the information available to management of Select Medical today, and the company assumes no obligation to update these statements as circumstances change.
At this time, I will turn the conference call over to Mr. Robert Ortenzio.
Robert Ortenzio
Thanks, operator. Good morning, everyone. Welcome to Select Medical's earnings call for the fourth quarter of 2023. Before providing details on each of our four operating divisions, I will provide some updates and commentary on the business. As most of you know, on January 3, 2024, we announced that our Board of Directors has approved a plan to pursue the separation of Select Medical's wholly-owned occupational health services business, Concentra.
As I have previously stated, we are pursuing the separation of Concentra with the objective of enhancing shareholder value and the success of each business by creating two companies that will be leaders in their respective markets. The potential separation is intended to be affected in a tax-free manner to Select Medical and its stockholders and to be completed in 2024....
Read the full article on Seeking Alpha
For further details see:
Select Medical Holdings Corporation (SEM) Q4 2023 Earnings Call Transcript